Category Copyright Policy

At WTO Next Week: GI Register, Plain Packaging, Women In Innovation

The next meeting of the World Trade Organization intellectual property committee is expected to include discussions on women and innovation, and concerns about legislative efforts in the United Kingdom and Ireland to introduce plan packaging for tobacco products. Prior to the meeting, informal consultations will be held on the negotiating issue of an international register for geographical indications (GIs) for wines and spirits.

The Role Of Social Media In M&A Transactions

Despite the ever-increasing use of social media by businesses, social media assets are often overlooked in merger and acquisition (M&A) transactions. When addressing a company’s assets in a purchase agreement, social media assets tend to be explicitly addressed only very briefly, or not at all. It is important to address such assets explicitly, as they do not always constitute intellectual property rights covered by IP representations and warranties.

Circuit Courts Open As Satellites Of China’s Supreme People’s Court

After long preparations, the Second Circuit Court of China’s Supreme People’s Court was officially instituted in Shenyang city, Liaoning province in northeast China on 31 January. Qiang Zhou, president and chief judge of China’s Supreme People’s Court, attended and addressed the nameplate unveiling ceremony of the Second Circuit Court.

Special Report: Will India Bend To US Pressure On IP Rights?

It is no secret that the United States has been scaling up pressure on India to adopt intellectual property measures similar to those common in the United States and the European Union. But to what extent does India’s new government led by the business-friendly Narendra Modi see eye to eye with US official position? Can India, the “pharmacy of the world”, resolve the friction between pharmaceutical patents and access to affordable medicines without putting off foreign investors? The vitriolic and polarising debate surrounding these questions has got a fresh lease of life following US President Barack Obama’s landmark three-day visit to India this week.

While Indian and American business moguls are bullish about the future, Indian generic drug-makers as well as health activists within and outside India are deeply anxious about the shape of things to come